更新于：2024-11-01

Artificial Lens Implant Migration

人工晶状体移位

更新于：2024-11-01

基本信息

别名

Artificial Intra ocular Implant Dislocation、Artificial Intra-ocular Implant Dislocation、Artificial Lens Implant Dislocation

+ [3]

简介

The shifting and or tilting of implanted artificial lens resulting in impaired vision.

关联

项与人工晶状体移位相关的药物

Sodium Hyaluronate

玻璃酸钠

靶点-

作用机制-

在研机构

山东博士伦福瑞达制药有限公司 [+8]

原研机构

Seikagaku Corp.

在研适应症

角膜移植排斥反应 [+11]

非在研适应症-

最高研发阶段批准上市

首次获批国家/地区

日本

首次获批日期1986-11-29

项与人工晶状体移位相关的临床试验

NCT05458661 / Not yet recruitingN/A

Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort (BioBase)

The planned clinical investigation will be conducted to acquire raw data for the development of the algorithm. The data acquisition is intended to obtain first impressions of the potential performance of the changed hardware and software components and to confirm the safety profile assessed by risk analysis.

开始日期2022-08-01

申办/合作机构

Carl Zeiss Meditec AG

100 项与人工晶状体移位相关的临床结果

登录后查看更多信息

100 项与人工晶状体移位相关的转化医学

登录后查看更多信息

0 项与人工晶状体移位相关的专利（医药）

登录后查看更多信息

项与人工晶状体移位相关的文献（医药）

2024-06-01·Journal of Cataract & Refractive Surgery

Lens capsule pathological characteristics in cases of intraocular lens dislocation with atopic dermatitis

Article

作者: Shimoda, Masayuki ; Komatsu, Koji ; Ichihara, Kosuke ; Masuda, Yoichiro ; Nakano, Tadashi ; Kubota, Hoshiho ; Iida, Masanobu ; Iwamoto, Masami ; Kawai, Kenji ; Yamamoto, Naoki ; Iwauchi, Ai

Purpose:To explore lens capsule pathological characteristics in intraocular lens (IOL) dislocation after cataract surgery in patients with atopic dermatitis (AD).Setting:University hospital department of ophthalmology.Design:Case series with clinicopathological correlations.Methods:Lens capsules and surrounding tissues excised during surgery from eyes with AD (AD group) and eyes without AD (non-AD group) with IOL dislocation were histologically evaluated. Hematoxylin and eosin staining was used to assess abnormal changes in lens epithelial cells (LECs). Masson trichrome staining distinguished the fibrous metaplasia around the lens capsule into high-density and low-density fibrosis. Capsular splitting (thinning) was identified in both stained preparations.Results:The IOL dislocation morphology in the AD group (10 eyes of 10 patients) included 7 cases of capsular bag dislocation (CBD) and 3 cases of dead bag syndrome (DBS), with an average duration to IOL dislocation of 11.5 ± 5.6 years. All patients in the non-AD group (12 eyes of 12 patients) had CBD, averaging 10.2 ± 5.7 years to dislocation. Abnormal LECs, low-density fibrosis, and capsular splitting were observed in 9 (90), 9 (90), and 6 (60) of the patients in the AD group compared with 6 (50), 3 (25), and 2 (18), respectively, in the non-AD group (total n [%]).Conclusions:Compared with the non-AD group, the AD group exhibited higher frequencies of morphological changes in LECs, low-density fibrosis around the lens capsule, and capsular splitting characteristics of DBS. These results suggest LEC degeneration and increased lens capsule fragility occurred in patients with AD.

2020-08-01·Journal of the American College of Emergency Physicians Open

Recurrent and radiographically unrecognized iatrogenic intra‐prosthesis hip dislocations

作者: Cairns, Stephanie L. ; Jarman, Paul G. ; Fox, Olivia J. K.

AbstractHip dislocation is a common complication after total hip arthroplasty surgery. Newer prosthetic implants aim to reduce the risk of dislocation. The new dual mobility implant has a unique design that may result in intra‐prosthetic dislocation. We report a case of a recurrently missed iatrogenic intra‐prosthetic dislocation following closed reduction efforts in the emergency department (ED). Emergency physicians must be aware of the design, pitfalls, and management of this new prosthetic hip design.

2017-01-01·Plastic & Reconstructive Surgery2区 · 医学

Staged Suprapectoral Expander/Implant Reconstruction without Acellular Dermal Matrix following Nipple-Sparing Mastectomy

2区 · 医学

Article

作者: Harness, Jay K ; Salibian, Arthur H ; Mowlds, Donald S

Background:Since the introduction of nipple-sparing mastectomy as an oncologically safe procedure for the treatment of breast cancer, reconstructive efforts for immediate staged expander/implant reconstruction have focused on submuscular implantation with or without acellular dermal matrix. Suprapectoral reconstruction without acellular dermal matrix has received little attention in the reconstructive literature of nipple-sparing mastectomy.Methods:Between 2005 and 2015, 155 patients (250 breasts) underwent nipple-sparing mastectomy with prepectoral staged expander/implant reconstruction using thick mastectomy skin flaps without acellular dermal matrix. Patients with different breast sizes, including those patients with very large breasts who required a primary mastopexy, were considered candidates for the suprapectoral reconstruction. Tumor-related data, comorbidities, and preoperative or postoperative radiation therapy were evaluated for correlation with the final outcome.Results:Patients were followed up for an average of 55.5 months (range, 138.1 to 23.6 months). The tumor recurrence rate was 2.6 percent. Adverse outcomes such as capsular contracture, implant dystopia, and rippling were studied. Aesthetic outcome, based on a three-point evaluation scale, showed 53.6 percent of patients as having a very good result, 31.6 percent showing a good result, 9 percent showing a fair result, and 5.8 percent showing a poor result.Conclusions:The suprapectoral two-stage expander/implant reconstruction without acellular dermal matrix in nipple-sparing mastectomy has certain advantages with respect to breast shape, less morbidity related to expansion, ease of reconstruction, and cost effectiveness. These advantages have to be weighed against those of subpectoral reconstruction with acellular dermal matrix to determine the method of choice.CLINCAL QUESTION/LEVEL OF EVIDENCE:Therapeutic, IV.